What We Do
Stingray Healthcare Group
Where clinical expertise, innovation and collaborations advance precision cancer care.
Our Mission
Stingray Healthcare Group’s mission is to expand access to high-quality, patient-centred cancer care across Europe by bringing together clinical excellence, advanced treatment technologies, and a partnership-led model with healthcare professionals and institutions.
Through the integration of the Stingray and Amethyst networks, the Group strengthens oncology centres with long-term investment, innovation, and operational expertise — improving patient outcomes and expanding the reach of precision radiotherapy and integrated cancer care.
Medical Services
The Group delivers a comprehensive range of advanced cancer treatments across its European network — spanning radiotherapy, radiosurgery, brachytherapy and chemotherapy — each tailored to the individual patient by experienced multidisciplinary clinical teams.
By combining leading-edge medical technology with evidence-based clinical practice, our centres provide precise, effective and personalised care designed to achieve the best possible outcomes while prioritising patient safety, comfort and quality of life throughout the treatment journey.
Our Leaders
The leadership of Stingray Healthcare Group brings together experienced medical professionals, healthcare managers, and entrepreneurs with a shared commitment to advancing modern cancer care across Europe.
The leadership team focuses on long-term investment in cutting-edge technology, preserving clinical independence, and building a collaborative network of centres that enables healthcare professionals to deliver the best possible outcomes for their patients.
WHO WE ARE
About Stingray
Stingray Healthcare Group is Europe’s largest independent cancer care platform
We are dedicated to expanding access to high-quality, patient-centred oncology services across the continent. Headquartered in Lausanne, Switzerland, the Group unites leading radiotherapy and radiosurgery centres across Europe, combining deep clinical expertise with advanced medical technologies to deliver personalised cancer treatments and integrative care. Today, the Group operates more than 30 specialist treatment centres across eight European countries, treating approximately 40,000 patients each year with the support of multidisciplinary clinical teams and state-of-the-art radiotherapy equipment.
The Group works alongside medical professionals to strengthen and modernise oncology centres while preserving full clinical independence. By investing in modern infrastructure, advanced treatment technologies, and innovative solutions such as AI-enabled radiotherapy planning, Stingray Healthcare Group enables clinicians to deliver more precise treatments, expand capacity, and improve patient outcomes. Through collaboration, innovation, and long-term investment in healthcare infrastructure, the Group is building a connected network of world-class cancer care centres that supports health systems in meeting the growing demand for cancer treatment across Europe.




